CHRISTINA URCIUOLI: Open Payments
NPI 1285396986 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 19 payments from 10 companies in 2025. Trend: 2023 $790 · 2024 $762 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $124 |
| Madrigal Pharmaceuticals | 5 | $107 |
| ABBVIE INC. | 5 | $93 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: BREZTRI, REZDIFFRA, VRAYLAR, Rybelsus, LINZESS, Cologuard Collection Kit, UBRELVY, FARXIGA.
Industry payments across NY — which companies pay providers there.
